Photo : Financial Express
Leading Pharma Companies Cut Costs Of Remdesivir Injections
Leading pharmaceutical companies, including Cadila Healthcare, Dr. Reddy's Laboratories, and Cipla, have cut the cost of Remdesivir injection to ensure a wider availability of the COVID-19 drug. According to the NPPA, all the pharma companies have priced their Remsdesivir injections (100 mg/vial) in the range of Rs 2,500 to Rs 4,000. Notably, several states across the country have reported a shortage of the antiviral injection.
Tags: Dr Reddy's, Cipla, Indian Pharmacy, REMDESIVIR
Courtesy: Times now news
Photo: Economic Times
Dr Reddy's Disables Its Data Centers Following Digital-security Breach
After suffering a cyberattack recently, Indian pharmaceutical firm Dr Reddy's has disabled all its data centres. Reportedly, the company witnessed data breach at its plants in India, US, Brazil, Russia and UK. However, the drugmaker stated that the impact of the cyberattack was not severe and the services suspended will be put back on track after 24 hours. The company's shares nosedived by 4.3% following the news.
Tags: Dr Reddy's, Cyber Attack, Indian Pharmacy, cybersecurity
Courtesy: Reuters
Photo: Mumbai Mirror
NPPA Regulates Price of Medical Oxygen After Complaints of Hoarding
National Pharmaceutical Pricing Authority (NPPA) has fixed the price of medical oxygen to make sure its availability and fair price. The action was taken after complaints regarding black-marketing and stocking of cylinders went high. Reportedly, Illegal practices shot up as the demand for oxygen during the COVID-19 pandemic increased four times. Earlier, the Health Ministry gave NPPA a leeway to regulate the supply and pricing of medical… read-more
Tags: oxygen cylinders, NPPA, Indian Pharmacy, Health Ministry, Covid-19, hoarding
Courtesy: Hindustan Times
